Biocept, Inc.
BIOC
BIOC was delisted on the 24th of October, 2023.
8 hedge funds and large institutions have $793K invested in Biocept, Inc. in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
74% more capital invested
Capital invested by funds: $455K → $793K (+$338K)
33% more funds holding
Funds holding: 6 → 8 (+2)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$385K |
| 2 |
GCM
Goldman Capital Management
New York
|
+$209K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$75.3K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$25.1K |
| 5 |
MWM
Merriman Wealth Management
Seattle,
Washington
|
+$16.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$18K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
-$8.36K |
| 3 |
GBA
Garrison Bradford & Associates
New York
|
-$8.36K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $319K | +$385K | +46 | New |
|
|
GCM
2
Goldman Capital Management
New York
| $176K | +$209K | +25 | New |
|
|
3
Vanguard Group
Malvern,
Pennsylvania
| $174K | +$75.3K | +9 | +56% |
|
|
BIT
4
BlackRock Institutional Trust
San Francisco,
California
| $44K | – | – | – |
|
|
BFA
5
BlackRock Fund Advisors
San Francisco,
California
| $24K | +$25.1K | +3 | New |
|
6
Geode Capital Management
Boston,
Massachusetts
| $21K | – | – | – |
|
|
GBA
7
Garrison Bradford & Associates
New York
| $20K | -$8.36K | -1 | -25% |
|
|
MWM
8
Merriman Wealth Management
Seattle,
Washington
| $12K | +$16.7K | +2 | New |
|
|
IP
9
Intellectus Partners
San Francisco,
California
| $2K | – | – | – |
|
|
LTFS
10
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
|
11
Citadel Advisors
Miami,
Florida
| – | -$18K | -1 | Closed |
|
|
12
Creative Planning
Overland Park,
Kansas
| – | -$8.36K | -1 | Closed |
|
|
13
UBS Group
Zurich,
Switzerland
| – | -$6K | – | – |
|
BIOC Hedge Fund Activity: Q4 2016 in Review
8 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q4 2016, worth a combined $793K — up 74% from $455K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BIOC positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $385K. The largest seller was Citadel Advisors, exiting entirely with an estimated $18K sold.
- 8 institutional investors held Biocept, Inc. (BIOC) as of Q4 2016, up from 6 in Q3 2016.
- Funds reported $793K of Biocept, Inc. stock for Q4 2016, up 74% quarter-over-quarter.
- 4 funds opened new Biocept, Inc. positions in Q4 2016 and 2 closed out, a net change of +2 holders.
- The largest Biocept, Inc. buyer in Q4 2016 was Sabby Management, an estimated $385K added.
- The largest Biocept, Inc. seller in Q4 2016 was Citadel Advisors, an estimated $18K sold.
Based on aggregated 13F filings for Q4 2016.